[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"European Georges Pompidou Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":125},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,37,65,91],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":32,"leadSponsor":34,"locationsCount":4},"100641293","postoperative-urinary-retention-management-in-the-post-anesthesia-care-unit-100641293",false,"NCT07655713","Postoperative Urinary Retention Management in the Post Anesthesia Care Unit","GEstion de la REprise MIctionnelle en Salle de Surveillance Post-interventionnelle\u002F Management of Postoperative Urinary Void Recovery in the Post-Anesthesia Care Unit","GEREMIS","Inclusion Criteria:\n\n* Patient admitted to the PACU for post-operative monitoring (excluding outpatient\u002Fambulatory and endoscopy cases)\n* Standard post-operative monitoring (transfer to a surgical ward after the monitoring period)\n* Adult patient (≥18 years)\n\nExclusion Criteria:\n\n* Post-operative care following urological surgery\n* History of chronic urinary retention\n* Presence of an indwelling urinary drainage system upon arrival in the PACU (urinary catheter, Bricker ileal conduit, suprapubic catheter)\n* Chronic renal failure requiring dialysis\n* Transfer to intensive care after the PACU monitoring period\n* Patient under legal protection (guardianship\u002Fconservatorship)","ALL","18 Years",{"count":20,"type":21},970,"ESTIMATED","OBSERVATIONAL","Introduction : The post-anesthesia care unit (PACU) admits patients in the immediate post-operative period in order to ensure monitoring, prevention, and management of early complications related to anesthesia and surgery. Post-operative urinary retention (POUR), inability to urinate despite a full bladder, is a common complication. Its incidence, causes, contributing factors, and complications have been the subject of numerous studies. Although well known, this complication has never had a consensus definition, particularly in terms of bladder volume, and the clinical signs known in urology are not always present post-operatively, notably pain and a feeling of fullness. In the event of POUR, bladder catheterization (intermittent catheterization, indwelling catheter placement, or suprapubic catheter) is often unavoidable, even though some studies have explored the possibility of pharmacological treatment. This procedure is invasive and carries its own risks: infection, trauma, bleeding, pain, discomfort, and loss of privacy\u002Fdignity. The challenge is to monitor and manage the onset of POUR while limiting unnecessary catheterization. For this purpose, bladder ultrasound is recommended to measure bladder volume. Previously performed by physicians using medical ultrasound machines, the arrival on the market of portable bladder scanners, which are non-invasive and simple to use, has made it possible to extend this examination to nurses. This diagnostic tool is a valuable aid in cases of suspected POUR (presence of clinical signs) or for patients at risk of obstruction. It helps guide medical decision-making regarding bladder catheterization. These devices, which have been available on the market for about thirty years, have gradually been adopted by care units, likely limited by the cost of investment. The PACUs of our institution have been equipped with this device for less than 7 years, with one of them having acquired it more recently, in 2025. Experienced staff members in the department have reported a sense that the use of the device varies among professionals, and that the number of intermittent catheterizations performed in the PACU has increased since the device was introduced. In this context, we wish to evaluate our practices regarding the management of post-operative urinary voiding recovery, the appropriateness of bladder scanner uses in the PACU, and the appropriateness of bladder catheterization decisions. This project will describe practices regarding the management of urinary voiding recovery, analyze the appropriateness of bladder catheterizations, and help understand the clinical reasoning of healthcare staff. It is part of paramedical research on the evolution of practices with decision-support technologies.\n\nMethods: A nursing observational study on care practices, Single-center, mixed-methods study (prospective and retrospective), using data collected as part of routine care for the quantitative analysis and a practice survey by questionnaire addressed to healthcare staff for the qualitative analysis. Data will be collected as part of routine care from medical records (PACU monitoring sheet and electronic patient record) and from a study-specific data collection form for the prospective component, allowing further detail on the modalities of nursing care. Data will be collected over the period between admission to the PACU and the 24 hours following discharge from the PACU. The medical records of 970 patients will be analyzed (485 retrospectively and 485 prospectively). In addition, an anonymous questionnaire will be given to nursing staff working in the PACU, to explore current knowledge and practice habits.",[25],"Management of Post-operative Urinary Voiding Recovery in the Post-anesthesia Care Unit, Management of Post-opérative Urinary Retention","NOT_YET_RECRUITING","2026-06-12",{"date":29,"type":30},"2026-06-18","ACTUAL",{"date":27,"type":21},{"date":33,"type":21},"2026-08-29",{"name":35,"class":36},"European Georges Pompidou Hospital","OTHER",{"id":38,"slug":39,"hasResults":11,"nctId":40,"briefTitle":41,"officialTitle":42,"acronym":43,"eligibilityCriteria":44,"healthyVolunteers":45,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":46,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":48,"conditions":49,"keywords":51,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},"100597532","mic-mac-micro--and-macrocirculatory-assessment-during-cardiac-surgery-in-patients-at-risk-of-vasoplegic-syndrome-a-prospective-study-100597532","NCT07059715","Mic Mac: Micro- and Macrocirculatory Assessment During Cardiac Surgery in Patients at Risk of Vasoplegic Syndrome: A Prospective Study.","Mic Mac Study: A Prospective Study of Hemodynamic Coherence in Vasoplegic Syndrome After Cardiopulmonary Bypass","MicMac","Inclusion Criteria:\n\nHave at least 3 point of the following risk factors for post-body circulation vasoplegic syndrome:\n\n* Acute or chronic heart failure with left ventricular ejection fraction\\\u003C 40% (1 pt)\n* Complex cardiac surgery ( 2 pts)\n* Cardiovascular risk factors with a EuroSCORE\\> 4% (1 pt)\n* Chronic Kidney Disease Stage 4\n* Type 2 Diabetes Mellitus\n* Pre-operative heparin treatment\n* Hypothyroidism\n* Anti-hypertensive treatments including an ACE inhibitor, an angiotensin II receptor antagonist, a beta-blocker or Sacubitril\n\nExclusion Criteria:\n\n* Heart transplantation\n* Pre-operative hemodynamic instability\n* Pregnant women\n* Age \\\u003C18\n* Pre-existing sepsis\n* Extracorporeal circulation support\n* Heartmate\u002FImpella\u002FCarmat patient\n* Hypothalamo-hypophyseal pathologies\n* Adrenal insufficiency\n* Anuric patient\n* Guardianship\u002F curatorship\n* Lack of social security coverage\n* Opposition to clinical research by patients or their families",true,{"count":47,"type":21},50,"This research focuses on understanding the vasoplegic syndrome after cardiac surgery under extracorporeal circulation and in the aftermath of your surgery in the ICU.\n\nThe investigators evaluate variations in a number of clinical and biological parameters during cardiac surgery and in the 48 hours following resuscitation. In addition to all the monitors investigators usually use to monitor vital parameters during this type of procedure, investigators use sensors placed on the skin at the earlobe and palm of the hand to assess the quality of blood circulating in the body.\n\nThe investigators would like to know if these observations help us to better understand the vasoplegic syndrome (persistent drop in blood pressure requiring the administration of medication to maintain normal blood pressure), a known but poorly understood complication following cardiac surgery under extracorporeal circulation. Extracorporeal circulation is the pump that keeps the blood circulating in your body when the heart is stopped while the surgeon works on the heart.",[50],"Vasoplegic Syndrome of Cardiac Surgery",[52,53,54],"vasoplegia syndrome","post cardiopulmonary bypass","cardiac surgery","RECRUITING","2025-07-10",{"date":58,"type":30},"2025-07-11",{"date":60,"type":30},"2025-02-10",{"date":62,"type":21},"2026-12-31",{"name":35,"class":36},1,{"id":66,"slug":67,"hasResults":11,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":71,"eligibilityCriteria":72,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":73,"targetDuration":75,"studyType":22,"phases":4,"briefSummary":76,"conditions":77,"keywords":79,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},"100273416","survey-on-epidemiology-of-hypoparathyroidism-in-france-100273416","NCT02838927","Survey on Epidemiology of Hypoparathyroidism in France","Epi-Hypo: Survey on Epidemiology of Hypoparathyroidism in France","Epi-Hypo","Inclusion Criteria:\n\n* patient fro whom chronic hypoparathyroidism is diagnosed\n* patient living in France\n\nExclusion Criteria:\n\n* patient who does not want his data to be collected in this registry\n* pseudo-hypoparathyroidism\n* acute hypoparathyroidism",{"count":74,"type":21},3000,"20 Years","Very few data has been published on the epidemiology of hypoparathyroidism worldwide: none exists specifically for France. Hypoparathyroidism could led to complications. Here, the investigators plan to collect data about both epidemiology, medication and complication of hypoparathyroidism in France.",[78],"Hypoparathyroidism",[78,80,81],"Epidemiology","Medication Therapy Management","2024-09-22",{"date":84,"type":30},"2024-09-24",{"date":86,"type":30},"2016-07",{"date":88,"type":21},"2031-09",{"name":35,"class":36},57,{"id":92,"slug":93,"hasResults":11,"nctId":94,"briefTitle":95,"officialTitle":96,"acronym":97,"eligibilityCriteria":98,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":99,"targetDuration":101,"studyType":22,"phases":4,"briefSummary":102,"conditions":103,"keywords":109,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":117,"lastUpdatePostDateStruct":118,"startDateStruct":120,"completionDateStruct":122,"leadSponsor":124,"locationsCount":64},"100393802","cardio-oncology-registry-100393802","NCT04407780","Cardio-Oncology Registry","Cardio-Oncologie: étude Pilote évaluant la faisabilité, Utilité Concrète, Interdisciplinaire d'Une Unité Spécialisée","CONFUCIUS","Inclusion Criteria:\n\n* referred to cardio-oncology\n\nExclusion Criteria:\n\n* refusal to participate",{"count":100,"type":21},5000,"5 Years","Cardio-oncology is an emerging field. Most of the data available have been issued from either retrospective analysis, industry data or pharmacovigilance data. These data sources include a number of bias.\n\nCONFUCIUS is a single tertiary centre prospective registry including all patients who have been referred for cardio-oncology assessemnt.\n\nThe objectives are to provide a comprehensive vue of cardoi-oncology, enable to detect early signals of cardiotoxicity and enhance ancillary projetcts aiming at specific populations (e.g., type of cancer) and\u002For drugs.",[104,105,106,107,108],"Cancer","Cardiac Disease","Metabolic Syndrome","Arrhythmia","Heart Diseases",[110,111,112,113,114,115,116],"cancer","heart","cardiovascular","cardio-oncology","onco-cardiology","phamacology","precision medicine","2020-05-25",{"date":119,"type":30},"2020-05-29",{"date":121,"type":30},"2017-01-01",{"date":123,"type":21},"2027-06-01",{"name":35,"class":36},""]